K252674 is an FDA 510(k) clearance for the Solo Pace Fusion System (SOLOFUSE1). This device is classified as a Wire, Guide, Catheter (Class II - Special Controls, product code DQX).
Submitted by Solo Pace, Inc. (San Francisco, US). The FDA issued a Cleared decision on January 9, 2026, 137 days after receiving the submission on August 25, 2025.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1330.
| 510(k) Number | K252674 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | August 25, 2025 |
| Decision Date | January 09, 2026 |
| Days to Decision | 137 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DQX - Wire, Guide, Catheter |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 870.1330 |